CJC-1295 (with/without DAC)
Growth Hormone Releasing Hormone analog
Long-acting GH secretagogue.
Mechanism of Action
Stimulates pituitary GH and IGF-1 release.
Key Benefits
- Increased muscle mass
- Fat loss
- Better recovery
Common Uses
What to Expect
Onset
Improved sleep within 2–5 days; body composition changes at 4–8 weeks
Duration
Cumulative over 8–12 week cycle; IGF-1 elevation sustained during use
What Users Report
- Noticeably deeper, more restorative sleep within the first week — often the first sign it's working
- Vivid, memorable dreams (very commonly reported)
- Improved skin quality and elasticity — skin appears tighter and more hydrated within weeks
- Gradual but visible fat loss, especially around the midsection
- Increased lean muscle mass and improved body composition over the cycle
- Enhanced recovery between training sessions — less soreness, faster bounce-back
- Some initial water retention and mild joint puffiness that typically subsides after 1–2 weeks
Typical Timeline
Days 1–5: Sleep quality improves noticeably. Weeks 2–4: Skin improvements, possible initial water retention. Weeks 4–8: Visible body recomposition — fat loss and lean mass gain become apparent. Weeks 8–12: Full benefits; many users report looking and feeling significantly younger.
Side Effects
- Possible water retention
Dosage Protocol
With DAC: 100–200 mcg 1–3x/week subcutaneously. Without DAC: 100–200 mcg nightly. Cycles: 8–12 weeks on, 4–8 weeks off. Titrate up; monitor GH levels.
Always consult a physician before starting any peptide protocol.
Administration
Injection
FDA Status
Category 2 (potential reclassification 2026)
Stacks Well With
- Ipamorelin
Tags
Related peptides
Ipamorelin
Selective ghrelin mimetic – safest GH peptide.
Semaglutide
GLP-1 agonist
FDA-approved weight-loss powerhouse.
Tirzepatide
Dual GIP/GLP-1 agonist
Next-gen dual agonist (Mounjaro/Zepbound).
Epitalon
Epithalon
Telomere-extending longevity peptide.